Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.63 |
| ▸ | MPL | P40238 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24895084 | 1.00 | CSNK2A1 (0.63) | CSNK2A1MPLMEN1KMT2AALDH1A1 | |
| SCHEMBL1250277 | 0.86 | MCL1 (0.68) | CSNK2A1MPLMEN1KMT2AMCL1 | |
| SCHEMBL16355668 | 0.85 | CYP2A6 (0.55) | CSNK2A1MEN1KMT2AALDH1A1CA9 | |
| SCHEMBL5369132 | 0.82 | GRIN2D (0.57) | CSNK2A1MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL5353853 | 0.82 | GRIN2D (0.57) | CSNK2A1MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL216334 | 0.81 | CA12 (0.61) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL124773 | 0.81 | CA12 (0.61) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL29434908 | 0.81 | CA12 (0.61) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL6881678 | 0.81 | CA12 (0.50) | MPLMEN1KMT2ACA12CA1 | |
| SCHEMBL18775431 | 0.81 | CA12 (0.50) | MPLMEN1KMT2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114730665-B | Electrolyte for electrolytic capacitor and electrolytic capacitor | 富山药品工业株式会社 | 2024-12-20 | — | — | CN | disclosed |
| EP-3421549-B1 | COLORING COMPOSITION, INKJET RECORDING INK, INKJET RECORDING METHOD, AND INKJET PRINTER CARTRIDGE | FUJIFILM CORP (JP) | 2023-08-16 | — | — | EP | disclosed |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| WO-2023287067-A1 | ANTIBACTERIAL COMPOUND | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| US-11410848-B2 | Method of forming pattern, method of manufacturing semiconductor device, and pattern-forming material | KIOXIA CORPORATION (JP) | 2022-08-09 | — | — | US | disclosed |
| CN-114730665-A | Electrolytic solution for electrolytic capacitor and electrolytic capacitor | 富山药品工业株式会社 | 2022-07-08 | — | — | CN | disclosed |
| US-20210296116-A1 | METHOD OF FORMING PATTERN, METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE, AND PATTERN-FORMING MATERIAL | KIOXIA CORPORATION (JP) | 2021-09-23 | — | — | US | disclosed |
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | disclosed |
| WO-2017132463-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2017-08-03 | — | — | WO | disclosed |
| US-9622995-B2 | Treatment of disorders associated with G protein-coupled receptor 35 (GPR35) | Temple University—Of the Commonwealth System of Higher Education (US) | 2017-04-18 | — | — | US | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| EP-1556896-B1 | ANTI-REFLECTIVE COMPOSITIONS COMPRISING TRIAZINE COMPOUNDS | BREWER SCIENCE INC (US) | 2008-04-09 | — | — | EP | disclosed |
| EP-1556896-A4 | ANTI-REFLECTIVE COMPOSITIONS COMPRISING TRIAZINE COMPOUNDS | BREWER SCIENCE INC (US) | 2007-05-09 | — | — | EP | disclosed |
| US-7038328-B2 | Anti-reflective compositions comprising triazine compounds | BREWER SCIENCE INC. (US) | 2006-05-02 | — | — | US | disclosed |
| EP-1556896-A2 | ANTI-REFLECTIVE COMPOSITIONS COMPRISING TRIAZINE COMPOUNDS | Brewer Science, Inc. (US) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004036311-A2 | ANTI-REFLECTIVE COMPOSITIONS COMPRISING TRIAZINE COMPOUNDS | BREWER SCIENCE, INC. (US) | 2004-04-29 | — | — | WO | disclosed |
| US-20040072420-A1 | Anti-reflective compositions comprising triazine compounds | BREWER SCIENCE, INC | 2004-04-15 | — | — | US | disclosed |
| US-5990332-A | EXCELLENT IN CHARGE CONTROL OR CHARGE-ENHANCING PROPERTY, AND TONER FOR DEVELOPING ELECTROSTATIC IMAGES AND POWDERY PAINT FOR ELECTROSTATIC PAINTING | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1999-11-23 | — | — | US | disclosed |
| US-5976749-A | TONER FOR DEVELOPING ELECTROSTATIC IMAGES | ORIENT CHEMICAL INDUSTRIES, LTD (JP) | 1999-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, GRIN1 | CSNK2A1 3350/4885MPL 2902/4885MEN1 4073/4885 |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | CSNK2A1 1833/4885MPL 2514/4885MEN1 2531/4885 |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | IAPP, IRS1, HBB | CSNK2A1 2214/4885MPL 3558/4885MEN1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.